BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24820142)

  • 1. Remission criteria and activity indices in psoriatic arthritis.
    Acosta Felquer ML; Ferreyra Garrott L; Marin J; Catay E; Scolnik M; Scaglioni V; Ruta S; Rosa J; Soriano ER
    Clin Rheumatol; 2014 Sep; 33(9):1323-30. PubMed ID: 24820142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
    Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
    J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
    Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort.
    Lubrano E; De Socio A; Perrotta FM
    J Rheumatol; 2017 Aug; 44(8):1159-1164. PubMed ID: 28572467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
    Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
    Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
    Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world.
    Salaffi F; Ciapetti A; Carotti M; Gasparini S; Gutierrez M
    Biomed Res Int; 2014; 2014():528105. PubMed ID: 24967375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Composite Measure Remission Targets in Psoriatic Arthritis.
    Farkas F; Ikumi N; Elmamoun M; Szentpetery A; FitzGerald O
    J Rheumatol; 2021 Aug; 48(8):1272-1278. PubMed ID: 33722944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar levels of disease activity and remission rates in patients with psoriatic arthritis and rheumatoid arthritis-results from the Finnish quality register.
    Weman L; Salo H; Kuusalo L; Huhtakangas J; Kärki J; Vähäsalo P; Backström M; Sokka-Isler T
    Clin Rheumatol; 2024 Feb; 43(2):633-643. PubMed ID: 38153614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
    Kaneko Y; Kondo H; Takeuchi T
    J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
    Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
    Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriatic arthritis: improvement in outcomes but persistent sex difference - 5-year follow-up study of a Norwegian outpatient clinic population.
    Łosińska K; Michelsen B; Kavanaugh A; Korkosz M; Haugeberg G
    Scand J Rheumatol; 2024 Jan; 53(1):10-20. PubMed ID: 37656147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.
    Tanaka Y; Smolen JS; Jones H; Szumski A; Marshall L; Emery P
    Arthritis Res Ther; 2019 Jul; 21(1):164. PubMed ID: 31277720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices.
    Lubrano E; Scriffignano S; Azuaga AB; Ramirez J; Cañete JD; Perrotta FM
    RMD Open; 2020 Mar; 6(1):. PubMed ID: 32179713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria.
    Shahouri SH; Michaud K; Mikuls TR; Caplan L; Shaver TS; Anderson JD; Weidensaul DN; Busch RE; Wang S; Wolfe F
    Arthritis Rheum; 2011 Nov; 63(11):3204-15. PubMed ID: 21739423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional Study.
    Brikman S; Furer V; Wollman J; Borok S; Matz H; Polachek A; Elalouf O; Sharabi A; Kaufman I; Paran D; Elkayam O
    J Rheumatol; 2016 Sep; 43(9):1749-54. PubMed ID: 27252430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
    Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
    Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission in rheumatoid arthritis: a comparison of the 2 newly proposed ACR/EULAR remission criteria with the rheumatoid arthritis disease activity index-5, a patient self-report disease activity index.
    Rintelen B; Sautner J; Haindl P; Mai H; Brezinschek HP; Leeb BF
    J Rheumatol; 2013 Apr; 40(4):394-400. PubMed ID: 23378466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.
    Lisbona MP; Solano A; Ares J; Almirall M; Salman-Monte TC; Maymó J
    J Rheumatol; 2016 Sep; 43(9):1631-6. PubMed ID: 27370881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inconsistencies of the Disease Activity Assessment Tools for Psoriatic Arthritis: Challenges to Rheumatologists.
    Gezer HH; Duruöz MT; Nas K; Kılıç E; Sargın B; Kasman SA; Alkan H; Şahin N; Cengiz G; Cüzdan N; Gezer İA; Keskin D; Mülkoğlu C; Reşorlu H; Sunar İ; Bal A; Küçükakkaş O; Yurdakul OV; Melikoğlu MA; Baykul M; Ayhan FF; Bodur H; Çalış M; Çapkın E; Devrimsel G; Gök K; Hizmetli S; Kamanlı A; Keskin Y; Ecesoy H; Kutluk Ö; Şen N; Şendur ÖF; Tekeoğlu İ; Tolu S; Toprak M; Tuncer T
    Joint Bone Spine; 2022 May; 89(3):105296. PubMed ID: 34656752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.